Allscripts Healthcare Solutions (MDRX) Key Ratios
$4.88
As on 01-Sep-2026 10:30EDT
Market cap
$517 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | 0.61 | -18.47 |
| EBIT | -- | -- | -- | -169.59 | 11.96 |
| Net Profit | -- | -- | -- | -186.32 | 8.81 |
| EPS | -- | -- | -- | -184.31 | 6.88 |
| Book Value | -- | -- | -- | -12.36 | 0.19 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -- | -- | -9.78 | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | -- | -- | -7.13 |
| Return on Capital
| -- | -- | -- | -- | -6.18 |
| Return on Assets
| -- | -- | -- | -- | -4.40 |
| Debt to Equity (x)
| -- | -- | 0.22 | -- | -- |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
--
--
Profit after tax / Average Net worth * 100
ROA
--
--
Profit after tax / Average Total assets * 100
EBIT Margin
-9.78
--
Operating profit (EBIT) / Net Sales * 100
Revenue Growth
--
--
Year on year growth in net sales
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
Net Profit Growth
--
--
Year on year growth in profit after tax
Solvency
Debt to Equity
0.22
--
Total debt / Net worth
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
Current Ratio
2.95
--
Current Assets / Current Liabilities and Provisions
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
Operating Efficiency
Debtors to sales
29.88
--
Debtors outstanding / Net Sales * 100
Asset Turnover
--
--
Sales / Average Total Assets
Receivable days
91.58
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
40.29
--
Average Creditors / Cost of goods sold * 365
Valuation
Price / Earnings
-14.01
--
Current share price divided by earning per share in the last twelve months
Price / Book Value
1.19
--
Current share price divided by book value per share in the latest financial year
EV/EBITDA
16.85
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)